- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | CLSA Sees Atour (ATAT) as a Premium Alternative in China's Hotel Market | ||
| Fr | Full Truck Alliance (YMM) Transaction Revenue Expected to Surge Over 30% in 2026 | ||
| Fr | Macquarie Bullish on NIO (NIO) After Strong Volume Growth | ||
| Fr | China Internet Regulation Poses New Risks for PDD Holdings (PDD) | ||
| Fr | EPKINLY Trial Results Prompt Price Target Cut for Genmab (GMAB) | ||
| Fr | 10 Stock Titans With Massive Losses | ||
| Fr | UBS Reassesses Rollins (ROL) Ahead of Earnings, Maintains Neutral View | ||
| Fr | UBS Trims International Paper (IP) Target as Cost-Saving Efforts Continue | ||
| Fr | UBS Revises Scotts Miracle-Gro (SMG) Outlook as Consumer Staples Pressures Persist | ||
| Fr | Citi Turns More Positive on PPG as Housing Tailwinds Emerge | ||
| Fr | Susquehanna Lifts UPS Price Target, Maintains Neutral Stance | ||
| Fr | Wells Fargo Upgrades Cintas (CTAS) and Names it a Top Pick for 2026 | ||
| Fr | RBC Capital Trims Duke Energy (DUK) Target in Utilities Sector Preview | ||
| Fr | Wolfe Research Upgrades Target (TGT) Ahead of March Investor Day | ||
| Fr | Jefferies Cuts Cheniere (LNG) Target but Stays Constructive Ahead of Q4 | ||
| Do | Investing in Hard Money Loans: Generating Yield and Downside Protection in California's High-Value Real Estate Markets | ||
| Do | 14 High Yield Dividend Stocks with Sustainable Payouts | ||
| Do | Bank of America Trims McDonald's (MCD) Target as Oppenheimer Turns Bullish | ||
| Do | Jim Cramer on AAR Corp.: "I've Been Recommending AIR Forever" | ||
| Do | Jim Cramer on Moderna: "We Have to Wait and See" | ||
| Do | Jim Cramer on Chipotle: "What a Good Franchise at a Very Reduced Price" | ||
| Do | Jim Cramer on Ramaco Resources: "This May Be the Time That It Works" | ||
| Do | Wells Fargo Analyst Sees Potential in Argenx SE's (ARGX) Vyvgart, Increases PT to $1,317 | ||
| Do | BofA Reiterates Buy Rating on Ascendis Pharma (ASND) While Wells Fargo Analyst Raises PT | ||
| Do | H.C. Wainwright Sees Strength in Halozyme Therapeutics' ENHANZE Platform, Reiterates Buy Rating |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.